Skip to main content
Livermore
Livermore
ZHEN

Bayesian Capital Management, LP

SEC CIK
0001632551
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2022
Holdings of APLS by Bayesian Capital Management, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−13,104−100.0%Sold outHolders
Q1 202613,104$527.2K0.6%+13,104NewHolders
Q4 20250$00.0%−25,500−100.0%Sold outHolders
Q3 202525,500$577.1K0.1%+25,500NewHolders
Q2 20250$00.0%−37,900−100.0%Sold outHolders
Q1 202537,900$828.9K0.1%+37,900NewHolders
Q4 20240$00.0%−31,200−100.0%Sold outHolders
Q3 202431,200$899.8K0.1%+31,200NewHolders
Q1 20240$00.0%−17,275−100.0%Sold outHolders
Q4 202317,275$1.03M0.1%+17,275NewHolders
Q3 20230$00.0%−9,124−100.0%Sold outHolders
Q2 20239,124$831.2K0.1%−8,800−49.1%ReducedHolders
Q1 202317,924$1.18M0.1%+17,924NewHolders
Q3 20220$00.0%−11,600−100.0%Sold outHolders
Q2 202211,600$525.0K0.1%−2,400−17.1%ReducedHolders
Q1 202214,000$711.0K0.1%+14,000NewHolders